Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384158 · ClinicalTrials.gov registry record · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
A NA study of Neurobehavioral Components of Reward and Loss Valuation, sponsored by Virginia Polytechnic Institute and State University.
- Recruiting
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT05384158 is a NA study of Neurobehavioral Components of Reward and Loss Valuation that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 252 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05384158, a NA study of Neurobehavioral Components of Reward and Loss Valuation, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines how people respond to rewards and losses, and the extent to which these responses are linked or distinct among people experiencing depressed mood, anhedonia, and/or anxiety.
Conditions Studied
Interventions
- BEHAVIORAL cognitive behavioral therapy
- BEHAVIORAL valuation with instruction
- BEHAVIORAL valuation without instruction
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute at Virginia Tech Carilion - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05384158
The ClinicalTrials.gov registry entry for NCT05384158 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurobehavioral Components of Reward and Loss Valuation appearing as the primary indexed condition, and to 3 interventions - of which cognitive behavioral therapy is the first listed.
NCT05384158 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05384158 about?
NCT05384158 is a clinical study titled "Valuation in Depressed Mood, Anhedonia, and Anxiety". This study examines how people respond to rewards and losses, and the extent to which these responses are linked or distinct among people experiencing depressed mood, anhedonia, and/or anxiety.
What is the current status of trial NCT05384158?
This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2021-08-01. Estimated completion is 2026-07.
What conditions does trial NCT05384158 study?
This clinical trial studies the following conditions: Neurobehavioral Components of Reward and Loss Valuation.
What interventions are being tested in trial NCT05384158?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), valuation with instruction (BEHAVIORAL), valuation without instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05384158?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05384158 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.